On February 6 2019, Enorama Pharma decided to appoint a Nomination Committee to prepare the next Annual General Meeting's resolutions on election and remuneration issues. In the notice of the Annual General Meeting on May 24 2019, the Nomination Committee's proposal for election of Board members was presented. Re-election was proposed by Board members Mats Persson, Mats Rönngard, Tomas Eriksson and Chairman of the Board Anders Ermén. Current board member Anders Jungbeck declined re-election. Furthermore, the Nomination Committee proposed new elections of Bengt Jönsson and Anders Dahlin - two extremely meritorious contributions to Enorama Pharma's Board of Directors.